Shujath. Ali

Shujath Ali is a Senior Director Global MW Strategist at Bayer, where they have worked since 2017, focusing on New Drug Applications and driving complex clinical data communication strategies. With 17 years of experience in medical writing and regulatory submissions, Shujath has previously held positions at MDS Pharma Services, sanofi-aventis, and other prominent organizations, authoring pivotal regulatory documents and leading critical projects. They earned a PhD in Biochemistry from the University of Hawaii and completed a research fellowship at Harvard Medical School. Shujath's career reflects a strong background in clinical research and regulatory affairs.